AfterPullback: Biotech Stocks

AfterPullback: Biotech Stocks

“AfterPullback: Biotech Stocks” delivers a comprehensive overview of leading U.S.-traded biotech companies, along with emerging and innovative firms that have recently entered the public market. Our selection spans a variety of sectors within biotech, including gene editing, diagnostics, pharmaceuticals, immunotherapy, cancer treatment, regenerative medicine, and bioinformatics.

6 Symbols in watchlist.

Symbol
Price
Change %
Market Cap
Volume
MRNA $33.32 -1.44% $14.18B 6,295,489
PACB $1.96 +6.52% $570.70M 6,507,137
BNTX $103.22 -2.83% $25.95B 460,974
FLGT $23.67 +0.72% $729.72M 77,607
CRSP $66.91 +0.58% $6.73B 1,061,225
ILMN $99.87 +2.71% $14.67B 719,740
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.